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ABSTRACT: Fungal diseases are very common these days, so there is a high need to design and develop 
new antifungal drugs that can counter these diseases. Candida albicans is one of the opportunistic pathogenic 
yeasts that can cause serious diseases such as oropharyngeal candidiasis, vulvovaginal (genital) candidiasis, 
and invasive candidiasis (candidemia). This article focuses on the in-silico evaluation of anti-candidal activity 
of some natural compounds like ajoene, allicin, curcumin, gingerol, nimbin, nimbolide, nimonol and 6-
Shogaol. Binding affinity of these compounds have been determined against the most common targets in C. 
albicans viz. cytochrome p450, lanosterol synthase, serine/threonine protein kinase, squalene 
monooxygenase, sterol-14-demethylase and thymidylate synthase. PatchDock and FireDock web servers were 
used to carry out the docking studies. The proposed targets of ajoene, allicin, curcumin, gingerol, nimbin, 
nimbolide, nimonol and 6-Shogaol are sterol 14-demethylase, cytochrome p450, cytochrome p450, 
cytochrome p450, cytochrome p450, squalene monooxygenase, lanosterol synthase and squalene 
monooxygenase respectively based upon the binding energies obtained by the docking studies. This study 
opens new avenues in the usage of the natural compounds as potential antifungal agents. 
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1. INTRODUCTION 
Fungi are the group of eukaryotic microorganisms that digest food externally and absorb nutrients 
directly through their cell wall. Most of the fungi reproduce by spores and have a body (thallus) comprising of 
microscopic tubular cells called as hyphae. Fungi are heterotrophs and saprophytic in nature [1]. Some 
common examples of fungi are Candida species, Saccharomyces species, Aspergillus species, Cryptococcus 
species etc. 
Candida albicans exists in the yeast form of fungi. Multiple species of Candida are harmless 
commensals or endosymbionts of host including humans [2]. C. albicans majorly causes three types of 
infections including oropharyngeal candidiasis, vulvovaginal (genital) candidiasis, and invasive candidiasis 
(candidemia) [3].  
In comparison to the available antibacterial drugs, the antifungal drugs are very less. This is primarily 
due to the shortage of the antifungal targets owing to the eukaryotic nature of the fungi [4]. The available 
antifungal drugs are not free from side effects like nephrotoxicity under prolonged usage, epigastric pain, 
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headache, loss of appetite etc. [5]. In order to overcome the scarcity of the broad spectrum antifungal drugs it 
is mandatory to search for potential drug candidates amongst the natural compounds. With this concept in 
mind, the current manuscript focuses on determining the probable antifungals targets of certain natural 
compounds having unknown targets using in-silico approach. This is also accompanied by studying their 
interaction with their respective antifungal targets. Natural compounds obtained from neem (Azadirachta 
indica), ginger (Zingiber officinale), garlic (Allium sativum) and turmeric (Curcuma longa) have been studied 
in this manuscript with reference to their antifungal properties against C. albicans.  
Neem (Azadirachta indica) is a natural herb and its constituents have been demonstrated to exhibit 
anti-inflammatory, antiulcer, antimalarial, antifungal and anticarcinogenic properties. Amongst the different 
compounds present in neem, nimbin, nimbolide and nimonol are known to possess antifungal properties [6].  
Garlic (Allium sativum) is known for its antibacterial nature, property of reducing the blood pressure, 
improving cholesterol levels and also as an antifungal agent. Garlic contains allicin and ajoene compounds 
which have the ability to fight against the fungal pathogens [7, 8].  
Turmeric and ginger (Zingiber officinale) both belong to the Zingiberaceae family and are rhizomes. 
They both have anti-inflammatory and antifungal properties. Turmeric is also known for its healing properties. 
The main active compound present in turmeric is curcumin [9]. 
Ginger is loaded with nutrients and bioactive compounds such as gingerol and 6-Shogaol which are 
very beneficial and also work against the fungal pathogens like C. albicans [10]. 
These natural antifungal compounds have been tested for their interaction and activity against some 
commonly known targets present in C. albicans viz. cytochrome p450, lanosterol synthase, serine/threonine 
protein kinase, squalene monooxygenase, sterol 14 demethylase and thymidylate synthase in order to 
ascertain the anti-candidal activity of these compounds and their most probable target. 
2. MATERIALS AND METHODS 
2.1. Sequence retrieval 
The National Centre for Biotechnology Information (NCBI) was used to retrieve sequence data of 
cytochrome p450 (CAA21953.1), lanosterol synthase (AOW27286.1), squalene monooxygenase 
(AOW26497.1), thymidylate synthase (AOW27536.1), sterol 14-demthylase (AOW29509.1) and 
serine/threonine protein kinase (AOW28668.1) proteins.   
2.2. Homology modelling  
Phyre2 is a web based service which was used for the purpose of protein structure prediction [11]. 
FASTA sequences obtained from NCBI were utilized to predict the structure of cytochrome p450, lanosterol 
synthase, serine/threonine protein kinase, squalene monooxygenase, sterol 14 demethylase, and thymidylate 
synthase.  
2.3. Ligand structure retrieval 
PubChem (https://pubchem.ncbi.nlm.nih.gov) is a database which provides information about chemical 
molecules and their activities against biological assays. It is maintained by NCBI. In the current study it was 
used to retrieve the 3D structures of ajoene, allicin, curcumin, gingerol, nimbin, nimbolide, nimonol and 6-
Shogaol in SDF format.  
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2.4. OpenBabel 
OpenBabel [12] is downloadable software which is mainly used to interconvert chemical file formats. 
In this study, the SDF format of 3D structure of compounds (ajoene, allicin, curcumin, gingerol, nimbin, 
nimbolide, nimonol and 6-Shogaol) was converted into the PDB format using this software.  
2.5. PatchDock and FireDock 
Patchdock and FireDock [13, 14] are online web servers which have been used in this study for the 
purpose of molecular docking. Using the docking studies, the best suited targets for all the ligands (ajoene, 
allicin, curcumin, gingerol, nimbin, nimbolide, nimonol and 6-Shogaol) have been proposed.  
2.6. UCSF Chimera 
UCSF Chimera [15] is an extensible program for interactive visualization and analysis of molecular 
structure and related data, including density maps, supramolecules assemblies, sequence alignment, docking 
results and conformational ensembles. In this study, the results obtained by the FireDock were visualized and 
analyzed using chimera. 
2.7. RAMPAGE 
Rampage [16] is the web server which is used to check the number of residues in favoured region, 
allowed region and outlier regions of the proteins. Cytochrome p450, lanosterol synthase, serine/ threonine 
protein kinase, squalene monooxygenase, sterol 14 demethylase and thymidylate synthase were validated for 
their modelled structure using RAMPAGE. 
3. RESULTS  
The sequences of the proteins which were obtained from NCBI are cytochrome p450, lanosterol 
synthase, serine/ threonine protein kinase, squalene monooxygenase, sterol 14 demethylase and thymidylate 
synthase. The proteins along with their respective sequences in FASTA format have been mentioned                        
in Table 1.  
Phyre2 was used to determine the homology modelled structure of cytochrome p450, lanosterol 
synthase, serine/threonine protein kinase, squalene monooxygenase, sterol 14-demethylase and thymidylate 
synthase as shown in Figure 1. The relevant parameters (Confidence and Coverage) of all the models have 
been shown in Table 2. 
  
 
Table 1. Proteins along with their respective amino acid sequences obtained from NCBI. 
Proteins FASTA Sequence 
Cytochrome 
P450 
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Proteins FASTA Sequence 
Lanosterol 
Synthase 
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Figure 1. Structure of proteins: (a) cytochrome p450, (b) lanosterol synthase, (c) serine/ threonine protein kinase,                
(d) squalene monooxygenase, (e) sterol 14-demethylase, (f) thymidylate synthase. 
 
Table 2. Confidence in the model and query coverage of the modelled structures. 
Protein Confidence (%) Coverage (%) 
Cytochrome  P450 100.0 94 
Lanosterol synthase 100.0 94 
Serine/ Threonine protein kinase 100.0 19 
Squalene monooxygenase 100.0 98 
Sterol 14-demethylase 100.0 90 
Thymidylate synthase 100.0 93 
 
Table 3. Validation of the structures of modelled proteins using RAMPAGE. 
Protein 
Number of residues  
in favoured region 
Number of residues  
in allowed region 
Number of residues  
in outlier region 
Cytochrome P450 448 (89.6%) 33 (6.6%) 19 (3.8%) 
Lanosterol synthase 674 (93.1%) 31 (4.3%) 19 (2.6%) 
Serine/ Threonine protein kinase 196 (76.6%) 41 (16.0%) 19 (7.4%) 
Squalene monooxygenase 425 (92.8%) 25 (5.5%) 8 (1.7%) 
Sterol 14-demethylase 500 (95.8%) 17 (3.3%) 5 (1.0%) 
Thymidylate synthase 270 (90.9%) 17 (5.7%) 10 (3.4%) 
 
Number of residues in the favoured region, allowed region and outlier region for each modelled 
structure viz. cytochrome p450, lanosterol synthase, serine/threonine protein kinase, squalene 
monooxygenase, sterol 14 demethylase and thymidylate synthase were determined by Ramachandran Plot 
(using RAMPAGE webserver) and have been mentioned in Table 3. 
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The structure of the ligands (ajoene, allicin, curcumin, gingerol, nimbin, nimbolide, nimonol and           
6-Shogaol) obtained from PubChem have been shown in Figure 2. 
Molecular docking of a particular ligand with different targets revealed that the most probable target 
would be the one with the highest binding energy and with the highest number of hydrogen bonds. Such 




Figure 2. Structure of ligands: (a) ajoene, (b) allicin, (c) curcumin,(d) gingerol, (e) nimbin,  
(f) nimbolide, (g) nimonol, (h) 6-Shogaol. 
 
Table 4. Ligands along with their most probable targets, number of hydrogen bonds and respective binding energies.  
Ligand Target Binding energy 
No. of hydrogen 
bonds formed 
Ajoene Sterol 14-demethylase -43.04 0 
Allicin Cytochrome P450 -32.90 0 
Curcumin Cytochrome P450 -58.68 2 
Gingerol Cytochrome P450 -52.27 2 
Nimbin Cytochrome P450 -58.18 0 
Nimbolide Squalene monooxygenase -60.87 2 
Nimonol Lanosterol synthase -62.39 2 
6-Shogaol Squalene monooxygenase -54.53 1 
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The respective best bind structures having the highest binding energies of the ligands docked on their 




Figure 3. Target ligand complexes (a) sterol 14-demethylase vs ajoene, (b) cytochrome p450 vs allicin, (c) cytochrome 
p450 vs curcumin, (d) cytochrome p450 vs gingerol, (e) cytochrome p450 vs nimbin, (f) squalene monooxygenase vs 
nimbolide, (g) lanosterol synthase vs nimonol, (h) squalene monooxygenase vs 6-Shogaol. 
 
4. DISCUSSION 
C. albicans is the causal organism of candidiasis [17]. Recently, it has been estimated that ~700,000 
cases of invasive candidiasis occurs naturally throughout the world [18]. Maximum cases of infections are 
caused by C. albicans and other Candida species [19]. Therefore, it becomes very essential to design a drug 
against C. albicans with minimum or no side effects. In this manuscript, we have made an effort to test some 
natural compounds against C. albicans and to determine the most probable targets of those compounds in the 
pathogens. The in-silico articles are scarce when it comes to the antifungal activity of the said ligands. 
However, in-vitro articles are available in large numbers.  
According to a study in 2014, it was found that curcumin plays an important role in inhibition of         
C. albicans. The result of this study showed that the photodynamic theory can be utilized for reduction in the 
biofilm biomass of C. albicans, C. glabrata, and C. tropicalis. It was observed that the association of four 
LED fluences for light excitation with 40 μM concentration of curcumin at 18 J/cm2 resulted in an inhibition 
of up to 85% metabolic activity of the studied Candida species [9]. Another study performed on curcumin 
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showed that the minimum inhibitory concentration (MIC) and the minimum fungicidal concentration (MFC) 
of curcumin was found to be 800 μl and 1600 μl respectively [20]. According to a different study, it was found 
that curcumin modulated the proteolytic enzyme activities without down-regulating the gene expression 
against C. albicans. However, in host inflammatory responses, curcumin down-regulated IL-1β and IL-1α 
gene expression [21]. In 2016, a study concluded that curcumin (5-20 mM) inhibited C. albicans 
morphogenesis significantly and also exhibited considerable activity against biofilm formation [22]. 
According to Mahmoud et al. [6], neem contains nimonol that gives good response against C. albicans. 
Different types of extracts from neem leaves were found to have inhibitory effect on C. albicans. Neem is the 
natural compound which contains nimbin, nimbolide, nimonol etc. that bind to their respective targets and 
inhibit the growth of C. albicans [6]. Santos et al., determined the minimum inhibitory concentration (MIC) of 
Nimonol against of C. albicans to be 1000/500 μg//mL [23]. 
Yoshida et al. [8], showed that at less than 20 µg/ml of ajoene, growth of C. albicans was inhibited [8]. 
Similarly, allicin present in garlic was also found to have the ability to inhibit growth of C. albicans and 
reduce the MIC of amphotericin B while keeping the same efficacy [7]. In a different study allicin was found 
to contain allyl sulphur derivative of garlic. The MIC50 and MIC90 of allicin alone against six Candida spp. 
ranged from 0.05 to 25 μg/ml [24]. Bansal and co-workers in 2019 [25] showed that MIC of neem extract was 
5.0 mg/ml against C. albicans and antifungal activity was found to be highest for chlorhexidine (14.4 Mm) 
followed by neem [25]. 
In ginger, 6-gingerol and 6-Shogaol showed antifungal response against C. albicans. Lee et al. [10], 
showed that 6-gingerol and 6-shagaol had the intrinsic potential to reduce the C. albicans virulence in a 
nematode infection model. They also emphasized upon the antibiofilm and antivirulence activities of these 
compounds against drug resistant C. albicans [10]. According to Kandhan et al., the ethanolic extract of Z. 
officinale showed good antifungal activity at different concentrations with a maximum zone of inhibition of 
21 mm at concentration of 2000 μg/ml [26]. 
5. CONCLUSION  
The current manuscript focuses upon prediction of the antifungal targets of natural compounds (allicin, 
ajoene, curcumin, gingerol, nimbin, nimbolide, nimonol and 6-shogaol) against C. albicans. In conclusion, the 
best suited target for ajoene, allicin, curcumin, gingerol, nimbin, nimbolide, nimonol and 6-shogaol are sterol 
14-demethylase, cytochrome p450, cytochrome p450, cytochrome p450, cytochrome p450, squalene 
monooxygenase, lanosterol synthase and squalene monooxygenase, respectively. Although, these compounds 
have been tested in-silico but determination of their in-vitro and in-vivo antifungal activity is desirous. 
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